Mitocon Biopharma Released Job Openings On 24/02/2022.Mitocon Biopharma is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments and we are always coded to care.
Vacancy Details:
Mitocon Biopharma Recruiting Candidates with 00-05 Years of Experience for DSA-I/DSA-II–MICC(Medical information contact center) Position.Complete Details for the DSA-I/DSA-II–MICC(Medical information contact center) as follows.
Important Details :
- Location : Begumpet, Hyderabad
- No of Vacancies:NA
- Details of Salary:fresher:- 18000/-, Experienced: depends on present ctc.
- Opening date for online Application: 24/02/2022
- Mode of application :Walk In
- Time And Venue :26 FEB 2022(Saturday),10:00a.m to 12:00p.m,Vasant Towers, #1-11-251/1B,1st Floor, Begumpet, Hyderabad, Telangana 500016
- Contact: 1.Keerthi-HR-9154383165 2. Raghuveer pabba – 9030044678-CAO
Related Job : Himalaya Drug Company Hiring B. Pharma,B.Sc – Salary ₹ 55,00,000 – 70,00,000 P.A.
Job Description/Skills Required
Applicants: Voice process, Call center, call handlers, Medical information contact center, Patient Safety.
- Should have excellent communication skills.
- “SHOULD BE INTERESTED FOR NIGHTSHIFT”
- Job Description:
- Medical enquiry handling through verbal telephone and written enquiries from Healthcare Professionals (HCPs) / patients, other people and Consumers about the medical products.
- Receive information or inquiry through phone call/email/fax/mail & Generate reports and create a record in Track Wise in AWS.
- Ensure that all the calls are getting populated in AWS.
- Enter all the relevant information received through phone calls/email/fax/mail into AWS Log.
- Responsible for receiving phone calls related to adverse events, MI and PQC for book-in of cases received by all source types (phone call/email/fax/mail).
- Responsible for following good documentation practices while completing ADE and PQC questionnaire.
